Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting.
- DOI
- 10.1007/s40744-026-00855-0
- Published
- 2026 Jun
- Container
- Rheumatology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-026-00855-0,
title = {Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting.},
author = {Taylor PC and Kadakia A and Milligan J and Romero A and Howell O and Patel PA and Barlow S and Caporali R},
year = {2026},
journal = {Rheumatology and therapy},
doi = {10.1007/s40744-026-00855-0},
url = {https://doi.org/10.1007/s40744-026-00855-0}
}RIS
TY - JOUR TI - Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting. AU - Taylor PC AU - Kadakia A AU - Milligan J AU - Romero A AU - Howell O AU - Patel PA AU - Barlow S AU - Caporali R PY - 2026 JO - Rheumatology and therapy DO - 10.1007/s40744-026-00855-0 UR - https://doi.org/10.1007/s40744-026-00855-0 ER -
APA
PC, T., A, K., J, M., A, R., O, H., PA, P., S, B., & R, C. (2026). Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting.. Rheumatology and therapy. https://doi.org/10.1007/s40744-026-00855-0
Source records
- pubmed · retrieved 2026-09-27T08:50:42.957Z